Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Oktay Bilgir"'
Autor:
İlhan Koyuncu, Betül Koyuncu, Mehmet Can Uğur, Emin Koyun, Oktay Şenöz, Mustafa Doğduş, Oktay Bilgir
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 2, Pp 91-96 (2024)
Objective: Bruton tyrosine kinase inhibition in cardiac tissue causes inhibition of the PI3K-AKT signaling pathway, which is responsible for protecting cardiac tissue during stress. Therefore, there is an increase in the risk of arrhythmia. This stud
Externí odkaz:
https://doaj.org/article/8add0025dfdf44f3948fb5de6eb73102
Autor:
Ibrahim Halil Acar, Muzeyyen Aslaner Ak, Gulsah Akyol, Taha Ulutan Kars, Yildiz Ipek, Ayse Uysal, Figen Atalay, Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Birgul Onec, Hakan Keski, Mufide Okay Ozgeyik, Sebnem Izmir Guner, Esra Terzi Demirsoy, Oktay Bilgir, Birol Guvenc
Publikováno v:
Medicina, Vol 60, Iss 10, p 1623 (2024)
Background and Objectives: Acute myeloid leukemia and myelodysplastic syndrome are both clonal hematologic malignancies that primarily affect older adults. Current treatments for AML/MDS are both limited in number and efficacy. This study aims to eva
Externí odkaz:
https://doaj.org/article/3bac2331ab0843e7ac42188b71925530
Autor:
Mehmet Can Uğur, Sinem Namdaroğlu, Esma Evrim Doğan, Esra Turan Erkek, Nihan Nizam, Rafet Eren, Oktay Bilgir
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 3, Pp 181-187 (2021)
Objective: Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by isolated thrombocytopenia. While first-line treatments focus on inhibiting autoantibodies and platelet destruction, second- and third-line treatments
Externí odkaz:
https://doaj.org/article/4889de27400042f692dc99076688d4cc
Autor:
Nanişe Gizem FENER, Oktay BİLGİR
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S37- (2021)
Aim: Acute myeloid leukemia (AML) is characterized by the increase of high levels of myeloid cells in the bone marrow. In general, AML is a disease of older adults. Many adults with AML are unable to receive intensive chemotherapy because of its toxi
Externí odkaz:
https://doaj.org/article/0d1057b7277f4e689040a12fc2deff3f
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S35- (2021)
Objective: Acute myeloid leukemia (AML) is the disease of elderly patients. Therefore, a significant number of patients are not suitable for intensive induction chemotherapy. In this study, it was aimed to retrospectively evaluate patients with AML w
Externí odkaz:
https://doaj.org/article/c246f44a55ce40c3b2e811fe001acfba
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S51-S52 (2021)
Objective: Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder that can be especially seen in children and young adults. The clinical presentation of patients with LCH varies according to the sites of involvement. In about half of pati
Externí odkaz:
https://doaj.org/article/846014ba5b5945e6a8bbf73315f12edd
Autor:
Ayşe Hilal Eroğlu Küçükdiler, İrfan Yavaşoğlu, Cem Selim, Cansu Atmaca Mutlu, Abdullah Karakuş, Mahmut Bakır Koyuncu, Oktay Bilgir, Orhan Ayyıldız, Eyüp Naci Tiftik, Ali Zahit Bolaman
Publikováno v:
Leukemia Research Reports, Vol 16, Iss , Pp 100280- (2021)
We retrospectively evaluated the use of gemtuzumab ozogamicin (GO) in relapsed refractory (R/R) acute myeloid leukemia (AML) patients. Twenty-one CD33 positive R/R AML patients who received GO as a single agent in 4 hematology centers were included i
Externí odkaz:
https://doaj.org/article/45ce0eecfb3e4771bd9551a8db580cf6
Autor:
Nur Soyer, İbrahim C Haznedaroğlu, Melda Cömert, Demet Çekdemir, Mehmet Yılmaz, Ali Ünal, Gülsüm Çağlıyan, Oktay Bilgir, Osman İlhan, Füsun Özdemirkıran, Emin Kaya, Fahri Şahin, Filiz Vural, Güray Saydam
Publikováno v:
Turkish Journal of Hematology, Vol 34, Iss 1, Pp 27-33 (2017)
Objective: Chronic myeloproliferative neoplasms (CMPNs) that include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are Philadelphia-negative malignancies characterized by a clonal proliferation of one or seve
Externí odkaz:
https://doaj.org/article/93b0b3f3366447f1a13c05b2c903eb80
Autor:
Füsun Özdemirkıran, Bahriye Payzın, H. Demet Kiper, Sibel Kabukçu, Gülsüm Akgün Çağlıyan, Selda Kahraman, Ömür Gökmen Sevindik, Cengiz Ceylan, Gürhan Kadıköylü, Fahri Şahin, Ali Keskin, Öykü Arslan, Mehmet Ali Özcan, Gülnur Görgün, Zahit Bolaman, Filiz Büyükkeçeci, Oktay Bilgir, İnci Alacacıoğlu, Filiz Vural, Murat Tombuloğlu, Zafer Gökgöz, Güray Saydam
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 4, Pp 323-328 (2015)
INTRODUCTION: OBJECTIVE: Immune thrombocytopenia (ITP) is an immune mediated disease characterized by transient or persistent decrease of the platelet count to less than 100 × 109/l. Although it is included in a benign disease group, bleeding compli
Externí odkaz:
https://doaj.org/article/29a5baaa1b244bd4b304f1143ef351cb
Autor:
Serife Solmaz Medeni, Sinem Namdaroglu, Tugba Cetintepe, Can Ozlu, Funda Tasli, Zehra Hilal Adibelli, Oktay Bilgir, Erhan Tatar
Publikováno v:
Hematology Reports, Vol 10, Iss 3 (2018)
Atypical hemolytic uremic syndrome is a rare and progressive disease caused by uncontrolled alternative complement activation. Dysregulatıon of the complement activation results in thrombotic microangiopathy and multiorgan damage. A 29-yearold woman
Externí odkaz:
https://doaj.org/article/ec9aa86a703d4044a653635465b25f3c